Food and Drug Administration

Blood Products Advisory Committee

July 22, 2005


Review of OBRR's Research Program: Introductory Comments, Karen Midthun, MD, FDA (HTM) (PPT)

FDA's Critical Path Research Initiative & Intro to the CBER Research Program, Kathryn Carbone, MD, FDA (HTM) (PPT)

Office of Blood Research and Review Site Visit for Research, Jay Epstein, MD, FDA (HTM) (PPT)

CBER OBRR Division of Blood Applications, Alan Williams, PhD, FDA (HTM) (PPT)

Division of Emerging and Transfusion Transmitted Diseases (DETTD) Office Site Visit 2005, Hira Nakhasi, PhD, FDA (PDF) (PPT)

Division of Hematology Office Site Visit 2005, Basil Golding, MD, FDA (HTM) (PPT)